News

The two collaborated on research showing that quantum computing could greatly aid the design of mRNA-based medicines and treatments. IBM: International Business Machines . . . or “Incredible ...
While Moderna isn’t looking to replace classical computing with quantum entirely, the company is interested in building a “quantum-enabled biotechnology pipeline.” In conjunction with IBM, the ...
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicines Agreement with IBM includes investments in generative AI to ...
CAMBRIDGE, MA and ARMONK, NY / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM ...
The companies hope their effort could lead to improved confidence in vaccine programs and increase rates of vaccination. Moderna and IBM have partnered to explore technologies that could help ...
IBM refers to the model as one that can “learn the grammar of molecules.” “We are excited to partner with IBM to develop novel AI models to advance mRNA science, prepare ourselves for the era of ...
IBM and Moderna (MRNA) team up to explore utility of hybrid cloud and blockchain technology to enhance COVID-19 vaccine management and stem the spread of the contagion.
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM) today announced an agreement under which Moderna will explore ...
Moderna and IBM are joining forces to incorporate artificial intelligence (AI) and quantum computing into mRNA development, which was used to create Moderna’s COVID-19 vaccine. “We are … ...
CAMBRIDGE, MA and ARMONK, NY / April 20, 2023 / Moderna, Inc. (Nasdaq: MRNA), a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE: IBM) have announced an ...
Under the agreement, IBM will provide access to quantum computing systems, as well as expertise to assist Moderna in exploring cutting-edge life sciences use-cases powered by quantum technologies.
The Moderna partnership fits into IBM’s larger strategy for enabling organizations across different industry verticals to benefit from foundation models.